Impaired autophagy: The collateral damage of lysosomal storage disorders

被引:44
|
作者
Myerowitz, Rachel [1 ]
Puertollano, Rosa [2 ]
Raben, Nina [2 ]
机构
[1] St Marys Coll Maryland, Dept Biol, St Marys City, MD 20686 USA
[2] NHLBI, Cell & Dev Biol Ctr, NIH, 50 South Dr Room 3533, Bethesda, MD 20892 USA
来源
EBIOMEDICINE | 2021年 / 63卷
基金
美国国家卫生研究院;
关键词
Lysosome; Autophagy; Gaucher disease; Batten disease; Danon disease; Pompe disease; Cystinosis; ENZYME REPLACEMENT THERAPY; MOUSE MODEL; DISEASE; DEGRADATION; PROTEIN; BIOGENESIS; CYSTINOSIS; MUTATIONS; LAMP-2; TFEB;
D O I
10.1016/j.ebiom.2020.103166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lysosomal storage disorders (LSDs), which number over fifty, are monogenically inherited and caused by mutations in genes encoding proteins that are involved in lysosomal function. Lack of the functional protein results in storage of a distinctive material within the lysosomes, which for years was thought to determine the pathophysiology of the disorder. However, our current view posits that the primary storage material disrupts the normal role of the lysosome in the autophagic pathway resulting in the secondary storage of autophagic debris. It is this "collateral damage" which is common to the LSDs but nonetheless intricately nuanced in each. We have selected five LSDs resulting from defective proteins that govern widely different lysosomal functions including glycogen degradation (Pompe), lysosomal transport (Cystinosis), lysosomal trafficking (Danon), glycolipid degradation (Gaucher) and an unidentified function (Batten) and argue that despite the disparate functions, these proteins, when mutant, all impair the autophagic process uniquely. (C) 2020 The Authors. Published by Elsevier B.V.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Newborn screening for lysosomal storage disorders
    Matern, Dietrich
    Gavrilou, Dimitar
    Oglesbee, Deuin
    Raymond, Kimiyo
    Rinaldo, Piero
    Tortorelli, Silvia
    SEMINARS IN PERINATOLOGY, 2015, 39 (03) : 206 - 216
  • [42] Facial features of lysosomal storage disorders
    D'Souza, Andrea
    Ryan, Emory
    Sidransky, Ellen
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (06) : 467 - 474
  • [43] Lysosomal storage disorders
    Beck, M.
    MONATSSCHRIFT KINDERHEILKUNDE, 2007, 155 (07) : 653 - 661
  • [44] Newborn Screening for Lysosomal Storage Disorders
    Nakamura, Kimitoshi
    Hattori, Kiyoko
    Endo, Fumio
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2011, 157C (01) : 63 - 71
  • [45] Gene therapy for lysosomal storage disorders
    Gritti, Angela
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (09) : 1153 - 1167
  • [46] Prevalence of patients with lysosomal storage disorders and peroxisomal disorders: A nationwide survey in Japan
    Koto, Yuta
    Sakai, Norio
    Lee, Yoko
    Kakee, Naoko
    Matsuda, Junko
    Tsuboi, Kazuya
    Shimozawa, Nobuyuki
    Okuyama, Torayuki
    Nakamura, Kimitoshi
    Narita, Aya
    Kobayashi, Hiroshi
    Uehara, Ritei
    Nakamura, Yoshikazu
    Kato, Koji
    Eto, Yoshikatsu
    MOLECULAR GENETICS AND METABOLISM, 2021, 133 (03) : 277 - 288
  • [47] Possible Involvement of Genes Related to Lysosomal Storage Disorders in the Pathogenesis of Parkinson's Disease
    Rudenok, M. M.
    Alieva, A. Kh.
    Nikolaev, M. A.
    Kolacheva, A. A.
    Ugryumov, M. V.
    Pchelina, S. N.
    Slominsky, P. A.
    Shadrina, M. I.
    MOLECULAR BIOLOGY, 2019, 53 (01) : 24 - 31
  • [48] Pompe disease: Shared and unshared features of lysosomal storage disorders
    Lim, Jeong-A
    Kakhlon, Or
    Li, Lishu
    Myerowitz, Rachel
    Raben, Nina
    RARE DISEASES, 2015, 3 (01)
  • [49] Autophagy, mitochondria and cell death in lysosomal storage diseases
    Kiselyov, Kirill
    Jennigs, John J., Jr.
    Rbaibi, Youssef
    Chu, Charleen T.
    AUTOPHAGY, 2007, 3 (03) : 259 - 262
  • [50] ARE ENZYME REPLACEMENT THERAPIES EFFECTIVE AGAINST LYSOSOMAL STORAGE DISORDERS?
    Hassan, Taimoor
    Huadong, Xu
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2021, 19 (02): : 73 - 77